Å·ÃÀAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Stability IV: Developments in stability testing and evaluation

21 March 2019 10:00-17:00, London, United Kingdom


Introduction
Continuing our successful series of stability meetings, this is an essential event for anyone concerned with the management and assessment of drug stability:
• Hear from individuals involved in the regulation and inspection of stability and GDP
• Learn from industry experts on scientific developments in stability study design and interpretation
• Debate practical issues for evaluating data and predicting stability
• Examine ways to improve compliance and productivity in stability testing
• Network with other professionals and exhibitors

Useful links

Speakers
  • Dr Jonathan Bright AstraZeneca, United Kingdom
  • John Cleverley Clarivate Analytics, United Kingdom
  • Dr Paul Fullerton AMRI, United Kingdom
  • Conor Jamieson Sandwell and West Birmingham NHS Trust, United Kingdom
  • Dr Nigel McSweeney FreeThink Technologies Inc, United Kingdom
  • Dr Rachel Orr GSK, United Kingdom
  • Dr Garry Scrivens Pfizer, United Kingdom
  • Susan Smith AstraZeneca, United Kingdom

Venue
The Å·ÃÀAV

The Å·ÃÀAV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Organised by
JPAG
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*